Liraglutide is a recombinant DNA produced polypeptide analogue of human  glucagon -like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. There have been no published reports of hepatotoxicity attributed to liraglutide therapy.

3. Product Benefits

1. Improves Type 2 Diabetes
 

Liraglutide can help control blood glucose. 

It can also reduce hyperglycemia, especially after meals (via enhanced secretion, delaying gastric emptying and suppressing glucagon secretion) for up to 24 hours.

2. Fights Obesity

Liraglutide can decrease appetite and caloric intake, while inhibiting weight gain.

3. Protects The Brain

In animal models, liraglutide can improve cognitive function. 

In stroke, liraglutide significantly decreases the damage size, improves neurologic deficits, and lowers stress-related hyperglycemia (also increasing expression of NeuN, GFAP, vWF, and GLP-1R). 

It can do this by lowering the amount of reactive oxygen species (ROS) in the brain and preventing glutamate-induced excitotoxicity. 
 

4. Has Anti-Anxiety Properties

Liraglutide in animal models has shown to have anti-anxiety properties. 

It doesn't show as great of an anti-depressant action as sitagliptin.
 

5. Has Anti-Inflammatory and Anti-Oxidant Properties

4. Product Side Effects

Common side effects of liraglutide may include:

• low blood sugar;

• nausea, vomiting, stomach discomfort, loss of appetite;

• diarrhea, constipation;

• rash;

• headache, dizziness; or

• feeling tired.

FAQ